Pharmaceutical

Repare bags $40m from Roche as solid tumour trial begins

The milestone-based payment came from Roche after Repare dosed the first patient with personalised solid-tumour treatment camonsertib.

Jan 25, 2024 - 18:00
Repare bags $40m from Roche as solid tumour trial begins
The milestone-based payment came from Roche after Repare dosed the first patient with personalised solid-tumour treatment camonsertib.
Read the original article

Tags:

Previous Article

Lava signs collaboration agreement with MSD for prostate cancer therapy

Next Article

Gilead’s Tecartus escapes harsher classwide boxed warning for CAR-T therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Microparticle analysis: methods and uses in the pharmaceutical industry

Microparticle analysis: methods and uses in the pharmac...

May 10, 2023

Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis 

Health Canada approves Arcutis’ ZORYVE foam for seborrh...

Oct 22, 2024

STAT+: Medical leaders decry Supreme Court decision on affirmative action

STAT+: Medical leaders decry Supreme Court decision on ...

Jul 2, 2023